Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.73 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.73 |
| ▸ | TSHR | P16473 | 1/20 | 0.73 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | GNE | Q9Y223 | 1/20 | 0.48 |
| ▸ | MGAM | O43451 | 1/20 | 0.47 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.46 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | ECE1 | P42892 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29527455 | 1.00 | KDM4E (0.73) | KDM4EALOX15TSHRACMSDTDP1 | |
| Hydrochloric Acid SCHEMBL3044758 | 0.98 | KDM4E (0.70) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL34595 | 0.85 | KDM4E (1.00) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL720696 | 0.85 | KDM4E (1.00) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL11294102 | 0.82 | KDM4E (0.94) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL2276248 | 0.82 | KDM4E (0.94) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL3974347 | 0.82 | KDM4E (0.94) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL9491853 | 0.82 | KDM4E (0.94) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL6556692 | 0.82 | KDM4E (0.94) | KDM4EALOX15TSHRACMSDTDP1 | |
| Dipicolinic Acid SCHEMBL6561776 | 0.82 | KDM4E (0.94) | KDM4EALOX15TSHRACMSDTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 832 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146180-A1 | CERIA BASED COMPOSITIONS AND METHODS FOR HARD CARBON POLISHING | ENTEGRIS, INC. (US) | 2026-05-28 | — | — | US | claimed |
| CN-122057575-A | Novel metal-organic framework supported catalyst, preparation method and photocatalytic CO thereof2Reduction application | 大连理工大学 | 2026-05-19 | — | — | CN | claimed |
| CN-122010834-A | Piroctone derivative, and preparation method and application thereof | 中国海洋大学 | 2026-05-12 | — | — | CN | claimed |
| EP-4679087-A1 | BIOMARKER AND USE THEREOF | MEIJI CO., LTD (JP) | 2026-01-14 | — | — | EP | claimed |
| CN-119082658-A | High-strength and high-toughness microalloy structural steel and preparation method thereof | 河北纵横集团丰南钢铁有限公司 | 2024-12-06 | — | — | CN | claimed |
| WO-2024190663-A1 | BIOMARKER AND USE THEREOF | 株式会社明治 | 2024-09-19 | — | — | WO | claimed |
| US-12077680-B2 | Polishing composition, production method of the same, polishing method and a manufacturing method of a semiconductor substrate | FUJIMI INCORPORATED (JP) | 2024-09-03 | — | — | US | claimed |
| CN-118491563-A | Preparation method of metal-organic framework supported iridium-based catalyst and photocatalytic CO2Reduction application | 大连理工大学 | 2024-08-16 | — | — | CN | claimed |
| CN-117797871-A | Be applied to catalytic CO 2 Para-metal site catalyst for preparing N, N-dimethylformamide by hydrogenation and preparation method thereof | 中国石油大学(华东) | 2024-04-02 | — | — | CN | claimed |
| CN-117003742-A | CPP (CPP) of fluorescent probe for detecting aluminum ions and preparation method and application thereof | 江苏科技大学 | 2023-11-07 | — | — | CN | claimed |
| US-5364939-A | Chlorinating hydroxy carboxylic acid with phosphorus pentachloride in phosphoroxy chloride | LONZA LTD. (CH) | 1994-11-15 | — | — | US | claimed |
| US-5270203-A | Biologically pure culture of Alcaligenes faecalis DSM 6335 | LONZA LTD. (CH) | 1993-12-14 | — | — | US | claimed |
| US-5268294-A | Mutants | LONZA LTD. (CH) | 1993-12-07 | — | — | US | claimed |
| US-5264361-A | Biosynthesis, alcalgenes | LONZA LTD. (CH) | 1993-11-23 | — | — | US | claimed |
| EP-0561421-A1 | Process for the preparation of carboxylic acid chlorides of aromatic nitrogen-containing heterocycles | LONZA AG (CH) | 1993-09-22 | — | — | EP | claimed |
| US-5238830-A | Cultivating aerobic biomass with picolinic acid or soluble salt and mineral acid, hydroxylating with biomass | LONZA LTD. (CH) | 1993-08-24 | — | — | US | claimed |
| US-5182197-A | Alcaligenes | LONZA LTD. (CH) | 1993-01-26 | — | — | US | claimed |
| EP-0504818-A2 | Microbiological process for the preparation of 6-hydroxy picolinic acid | LONZA AG (CH) | 1992-09-23 | — | — | EP | claimed |
| EP-0498316-A1 | Microbiological process for the production of 6-hydroxypicolinic acid | LONZA AG (CH) | 1992-08-12 | — | — | EP | claimed |
| EP-0422765-A1 | Cosmetic composition | UNILEVER PLC (GB) | 1991-04-17 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260146180-A1 | CERIA BASED COMPOSITIONS AND METHODS FOR HARD CARBON POLISHING | PLOD1, H1-4, H1-5 | KDM4E 174/4885ALOX15 1116/4885TSHR 2593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.